Manager × security

Rhenman & Partners Asset Management AB AXSM holdings history

Who else holds this security? →

AXSOME THERAPEUTICS INC · CUSIP 05464T104 · CIK 1599882

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Rhenman & Partners Asset Management AB reported 63.05K AXSM (shares), valued at $15.43M, or 1.46% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.46%
Shares
63.05K
63,050
Reported value
$15.43M
USD

Shares decreased 1.18%; reported value increased 43.11%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.46%63,050SEC filing ↗Filed Aug 13, 2026
Q1 20261.33%63,800SEC filing ↗Filed May 14, 2026
Q4 20251.96%114,800SEC filing ↗Filed Feb 13, 2026
Q3 20252.32%172,800SEC filing ↗Filed Nov 13, 2025
Q2 20251.20%90,800SEC filing ↗Filed Aug 13, 2025
Q1 20251.47%109,600SEC filing ↗Filed May 14, 2025
Q4 20241.07%122,600SEC filing ↗Filed Feb 13, 2025
Q3 20240.89%122,600SEC filing ↗Filed Nov 13, 2024
Q2 20240.99%127,600SEC filing ↗Filed Aug 13, 2024
Q1 20241.09%143,600SEC filing ↗Filed May 14, 2024
Q4 20230.63%79,100SEC filing ↗Filed Feb 13, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.63%79,100$6.30MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 13, 2024
Q1 20241.09%143,600$11.46MShares increased 81.54%; reported value increased 82.02%, and weight changed +0.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20240.99%127,600$10.27MShares decreased 11.14%; reported value decreased 10.36%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20240.89%122,600$11.02MShares decreased 3.92%; reported value increased 7.27%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20241.07%122,600$10.37MShares unchanged; reported value decreased 5.85%, and weight changed +0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2025
Q1 20251.47%109,600$12.78MShares decreased 10.60%; reported value increased 23.23%, and weight changed +0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20251.20%90,800$9.48MShares decreased 17.15%; reported value decreased 25.85%, and weight changed -0.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20252.32%172,800$20.99MShares increased 90.31%; reported value increased 121.41%, and weight changed +1.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20251.96%114,800$20.97MShares decreased 33.56%; reported value decreased 0.09%, and weight changed -0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20261.33%63,800$10.78MShares decreased 44.43%; reported value decreased 48.57%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20261.46%63,050$15.43MShares decreased 1.18%; reported value increased 43.11%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Rhenman & Partners Asset Management AB · AXSOME THERAPEUTICS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1599882","quarter":"2026Q2","cusip":"05464T104"}

get_institutional_manager_history
{"cik":"1599882","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.